These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8200422)

  • 21. Antinociceptive effects of RB101(S), a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by (+)-HA966, a functional NMDA receptor antagonist: a c-Fos study in the rat spinal cord.
    Buritova J; Le Guen S; Fournié-Zaluski MC; Roques BP; Besson JM
    Eur J Pain; 2003; 7(3):241-9. PubMed ID: 12725847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of acute and chronic opioid withdrawal by a selective soluble guanylyl cyclase inhibitor.
    Sullivan ME; Hall SR; Milne B; Jhamandas K
    Brain Res; 2000 Mar; 859(1):45-56. PubMed ID: 10720614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of withdrawal in reinstatement of morphine-conditioned place preference.
    Lu L; Chen H; Su W; Ge X; Yue W; Su F; Ma L
    Psychopharmacology (Berl); 2005 Aug; 181(1):90-100. PubMed ID: 15739075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RB 101, a purported pro drug inhibitor of enkephalin metabolism, is antinociceptive in pregnant mice.
    Jayaram A; Singh P; Noreuil T; Fournié-Zaluski MC; Carp HM
    Anesth Analg; 1997 Feb; 84(2):355-8. PubMed ID: 9024028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins.
    Valverde O; Maldonado R; Fournie-Zaluski MC; Roques BP
    J Pharmacol Exp Ther; 1994 Jul; 270(1):77-88. PubMed ID: 8035345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of precipitated withdrawal from spinal morphine: changes in [Met5]enkephalin levels.
    Cridland RA; Sutak M; Jhamandas K
    Eur J Pharmacol; 1991 Oct; 203(1):93-103. PubMed ID: 1797559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
    Cavun S; Göktalay G; Millington WR
    J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Weak tolerance to the antinociceptive effect induced by the association of a peptidase inhibitor and a CCKB receptor antagonist.
    Valverde O; Blommaert AG; Fournié-Zaluski MC; Roques BP; Maldonado R
    Eur J Pharmacol; 1995 Nov; 286(1):79-93. PubMed ID: 8566154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of morphine tolerance and dependence by diazepam and its relation to cyclic AMP levels in discrete rat brain regions and spinal cord.
    Sheu MJ; Sribanditmongkol P; Santosa DN; Tejwani GA
    Brain Res; 1995 Mar; 675(1-2):31-7. PubMed ID: 7796144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of glutamate in the locus coeruleus during opioid withdrawal and effects of H-7, a protein kinase inhibitor, on the action of glutamate in rats.
    Tokuyama S; Zhu H; Wakabayashi H; Feng YZ; Ho IK
    J Biomed Sci; 1998; 5(1):45-53. PubMed ID: 9570513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of mixed (RB 38A) and selective (RB 38B) inhibitors of enkephalin degrading enzymes on a model of depression in the rat.
    Tejedor-Real P; Micó JA; Maldonado R; Roques BP; Gibert-Rahola J
    Biol Psychiatry; 1993 Jul 1-15; 34(1-2):100-7. PubMed ID: 8373929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of the effects of a complete inhibitor of enkephalin-catabolizing enzymes, RB 101, by a cholecystokinin-B receptor antagonist in diabetic rats.
    Coudoré-Civiale MA; Méen M; Fournié-Zaluski MC; Boucher M; Roques BP; Eschalier A
    Br J Pharmacol; 2001 May; 133(1):179-85. PubMed ID: 11325808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of preproenkephalin knockout mice and selective inhibitors of enkephalinases to investigate the role of enkephalins in various behaviours.
    Noble F; Benturquia N; Bilkei-Gorzo A; Zimmer A; Roques BP
    Psychopharmacology (Berl); 2008 Feb; 196(2):327-35. PubMed ID: 17906961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat.
    Lee PH; McNutt RW; Chang KJ
    J Pharmacol Exp Ther; 1993 Nov; 267(2):883-7. PubMed ID: 8246163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ca2+ channel blocker, diltiazem, prevents physical dependence and the enhancement of protein kinase C activity by opioid infusion in rats.
    Tokuyama S; Feng Y; Wakabayashi H; Ho IK
    Eur J Pharmacol; 1995 Jun; 279(1):93-8. PubMed ID: 7556388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of neonatal rat morphine tolerance and dependence.
    Thornton SR; Wang AF; Smith FL
    Eur J Pharmacol; 1997 Dec; 340(2-3):161-7. PubMed ID: 9537810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Different roles of the spinal protein kinase C alpha and gamma in morphine dependence and naloxone-precipitated withdrawal].
    Cao JL; Ding HL; He JH; Zhang LC; Wang JK; Zeng YM
    Sheng Li Xue Bao; 2005 Apr; 57(2):161-8. PubMed ID: 15830100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of opioids and non-opioids on c-Fos-like immunoreactivity induced in rat lumbar spinal cord neurons by noxious heat stimulation.
    Abbadie C; Honoré P; Fournié-Zaluski MC; Roques BP; Besson JM
    Eur J Pharmacol; 1994 Jun; 258(3):215-27. PubMed ID: 8088356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The withdrawal syndrome and lipid peroxidation during the chronic administration of narcotic analgesics to rats].
    Konstantinopol'skiĭ MA; Pirozhkov SV; Solov'eva AG; Panchenko LF; Barkov NK
    Eksp Klin Farmakol; 1992; 55(1):21-4. PubMed ID: 1363943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Subchronic Intravenous Morphine Infusion and Naloxone-Precipitated Morphine Withdrawal on P-gp and Bcrp at the Rat Blood-Brain Barrier.
    Chaves C; Gómez-Zepeda D; Auvity S; Menet MC; Crété D; Labat L; Remião F; Cisternino S; Declèves X
    J Pharm Sci; 2016 Jan; 105(1):350-8. PubMed ID: 26554626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.